Apimeds Pharmaceuticals US, Inc.
$1.88
▲
7.43%
2026-04-21 05:21:01
www.mindwavedao.com
ASE: APUS
Explore Apimeds Pharmaceuticals US, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$23.64 M
Current Price
$1.88
52W High / Low
$40.31 / $1.61
Stock P/E
—
Book Value
$0.65
Dividend Yield
—
ROCE
126.09%
ROE
209.61%
Face Value
—
EPS
$-0.41
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
—
Beta
—
Debt / Equity
-0.44
Current Ratio
0.01
Quick Ratio
0.01
Forward P/E
—
Price / Sales
—
Enterprise Value
—
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Gelteq Limited | $0.7 | — | $7.5 M | — | -31.25% | -42.99% | $4.11 / $0.64 | $1.09 |
| 2. | Talphera, Inc. | $0.78 | — | $40.17 M | — | -52.04% | -1.15% | $1.57 / $0.38 | $0.34 |
| 3. | SCYNEXIS, Inc. | $1.07 | — | $47.85 M | — | -30.16% | -16.48% | $1.31 / $0.56 | $1.13 |
| 4. | Canopy Growth Corporation | $1.2 | — | $709.79 M | — | -8.06% | -48.5% | $3.28 / $1.18 | $1.49 |
| 5. | BGM Group Ltd. | $0.36 | — | $59.42 M | — | -0.81% | -3.37% | $17.17 / $0.27 | $1.85 |
| 6. | Lantheus Holdings, Inc. | $83.97 | 23.41 | $5.47 B | — | 16.66% | 21.45% | $108.91 / $47.25 | $16.87 |
| 7. | ANI Pharmaceuticals, Inc. | $81.73 | 23.13 | $1.81 B | 0.06% | 6.99% | 16.16% | $99.5 / $56.71 | $25.8 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -1.84 M | -2.66 M | -0.36 M | -0.28 M | -0.3 M |
| Net Profit | -1.78 M | -2.66 M | -0.4 M | -0.31 M | -0.33 M |
| EPS in Rs | -1.42 | -2.12 | -0.32 | -0.25 | -0.26 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -1.28 M | -0.75 M | -0.64 M | -1.02 M |
| Net Profit | -1.39 M | -0.78 M | -0.67 M | -1.03 M |
| EPS in Rs | -1.11 | -0.62 | -0.53 | -0.82 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 0.01 M | 0.42 M | 0.01 M | 0.17 M |
| Total Liabilities | 1.37 M | 0.39 M | 0.72 M | 0.41 M |
| Equity | -1.36 M | 0.03 M | -0.71 M | -0.24 M |
| Current Assets | 0.01 M | 0.42 M | 0.01 M | 0.17 M |
| Current Liabilities | 1.02 M | 0.12 M | 0.32 M | 0.01 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -0.73 M | -0.63 M | -0.45 M | -0.82 M |
| Investing CF | 0 M | 0 M | 0 M | 0 M |
| Financing CF | 0.33 M | 1.03 M | 0.28 M | 0.4 M |
| Free CF | -0.73 M | -0.63 M | -0.45 M | -0.82 M |
| Capex | — | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -78.73% | -16.31% | 34.84% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-03-26 | 1:0.1 |